27th Mar 2015 07:00
27 March 2015
Bagir Group Ltd.
("Bagir" or the "Company")
Final Results
for the year ended 31 December 2014
Bagir (AIM: BAGR), a designer, creator and provider of innovative formalwear tailoring, announces its results for the year ended 31 December 2014.
Financial highlights
· Revenue of $97.0m (2013: $99.5m)
· Gross margin of 17.4% (2013: 18.8%)
· Operating income of $0.5m (2013: $3.6m)
· Adjusted operating income of $3.4m* (2013: $5.6m)
· Profit (loss) before tax of $(3.2)m (2013: $(1.2)m)
· Adjusted profit (loss) before tax of $(0.3)m* (2013: $0.9m)
· Adjusted EBITDA of $3.8m** (2013: $6.1m)
· Basic and fully diluted earnings (loss) per share of $(0.09)*** (2013: $(0.39))
· Net debt at 31 December 2014 of $12.5m (31 December 2013: $50.3m)
· Cash and cash equivalents at 31 December 2014 of $11.4m (31 Dec. 2013: $2.7m)
* Adjusted for amortization of intangible assets of $2.4m, IPO expenses of $0.3m and non-recurring recovery plan consultancy costs of $0.2m (PBT including finance expenses on pre IPO debt)
** Adjusted for depreciation of $0.4m, amortization of $2.4m, IPO expenses and non-recurring recovery plan consultancy costs
*** Including finance expenses on pre IPO debt
Operational highlights
· Admission to trading on AIM in April 2014, raising approximately $29.7m after expenses
· Successfully grew revenues from new and other existing retail customers by approximately 30% (excluding work wear) to help compensate for the substantial loss of revenues from the Company's largest customer due to a change in that customer's buying strategy
· Acquisition of a 50% stake in Nazareth Garments Share Company ("Nazareth") in Ethiopia, for the manufacturing of garments for global sales
· Comprehensive review of the Company's business strategy and operating processes and commencement of a two year recovery plan
· Financial covenants have been reset with the Company's banks for the years 2015 and 2016, in line with the Company's updated financial projections
Danny Taragan, CEO of Bagir Group Ltd, said:
"2014 was a transformational year for Bagir with our successful IPO on AIM in April. However, the Company did suffer some headwinds during the period but, despite the reduction in sales from our largest customer, management expects to continue to grow revenues from other existing and new customers in the UK and in the US.
"The comprehensive review into the Company's business strategy and operating processes was successfully completed and a two year recovery plan has commenced. Once fully implemented, the recovery plan is expected to reduce the Company's operating costs, improve efficiency and enhance the Company's sales and marketing performance.
"The acquisition of Nazareth in November 2014 was an exciting development in Bagir's journey and this production facility in Ethiopia is expected to give Bagir a strong competitive advantage once the planned upgrades have been implemented. The Board thanks shareholders for their continued support and looks to the future with confidence."
For further information, please contact:
Bagir Group Ltd. Danny Taragan, Chief Executive Officer Udi Cohen, Chief Financial Officer
| via FTI Consulting |
N+1 Singer Jonny Franklin-Adams Alex Wright
| +44 (0) 20 7496 3000 |
FTI Consulting Alex Beagley / Tom Hufton | +44 (0) 20 3727 1000 |
Strategic and Financial Review
In April 2014, Bagir completed a successful admission to trading on the AIM Market of the London Stock Exchange, raising approximately £20.0 million (US$33.5 million) before expenses through the placing of 35,714,285 new shares. IPO related costs amounted to approximately $3.8 million.
As announced in May 2014, the business lost a substantial proportion of its planned revenue due to a change in the buying strategy by its largest customer. The Company has however successfully grown revenue elsewhere by approximately 30% (excluding workwear) through additional sales to other existing and new retail customers.
In November 2014, the Company purchased a 50% stake in Nazareth Garments Share Company ("Nazareth"), an Ethiopian company which owns and operates a garment factory in Ethiopia. As this business and its facilities are developed as part of Bagir's investment, it is expected to give Bagir a strong competitive advantage due to its duty free exports to the EU and US, its competitive production costs and government's support for the textile industry.
In September 2014 the Company announced a comprehensive review of its business strategy and operating processes. This review has been completed and the Company has commenced a two year recovery plan. This plan is designed to increase the competitiveness of our business through both operational improvements and cost reductions.
The Company will continue to focus on growing its quality tailored menswear private label business through existing and new customers. In addition, the Company is planning to further develop its brand licensing activity, mainly in the US, on a royalty paid basis. As part of the recovery plan the Company's production and management processes will be restructured, with efficiency improvements supported by additional IT development. Once fully implemented, the plan is expected to achieve significant annual cost reductions.
The comprehensive two year recovery plan and the increased competitive advantage of the new factory in Ethiopia along with the organic growth with customers and additional private label sales, are expected to deliver improved results in future years and strengthen the position of the Company in its market place.
The Company's financial covenants have been reset by its banks for the years 2015 and 2016, in line with the Company's updated financial projections.
Revenue
Revenue for the year ended 31 December 2014 was $97.0m. This was a $2.5m reduction on the comparable period last year, which was due mainly to the reduction in sales to the Company's largest customer and a large project for a customer that was completed by the Company during 2013, which as expected, did not continue into 2014. This was partly offset by increased revenues with other customers in the UK and in the US during 2014.
Gross margin
The gross margin for the year ended 31 December 2014 was 17.4% compared with 18.8% for 2013. This decline was mainly due to the reduction in business from the Company's largest customer, the completion of the large project mentioned above which had relatively higher margins, negative currency impact of the devaluation of the pound\dollar exchange rate and the higher depreciation of amortized intangible assets ($1.6m in 2014 compared to $1.1m in 2013).
Operating expenses
The general and administrative expenses increased to $4.3m in the period (2013: $3.7m), due predominantly to the additional administrative costs associated with being a quoted company. In addition, $0.3m one-off costs were incurred associated with the Company's IPO. These costs have been included as part of the Company's operating expenses for the period.
The two year recovery plan being implemented by the Company is, once fully implemented, expected to reduce operating costs going forward.
Adjusted operating income and profit (loss) before taxation
Adjusted operating income and profit (loss) before tax (before $2.4m amortization of intangible assets (2013: $2.0m) and before $0.3m IPO expenses and $0.2m non-recurring recovery plan consultancy costs) for the year ended 31 December 2014 was $3.4m and $(0.3)m respectively, compared with $5.6m and $0.9m respectively for 2013. The loss before tax was after finance expenses on pre-IPO debt.
Adjusted EBITDA
Adjusted EBITDA (before IPO expenses and non-recurring recovery plan consultancy costs) for the year ended 31 December 2014 was $3.8m (2013: $6.1m).
Loss per share
Basic and fully diluted earnings (loss) per share for the period was $(0.09) (2013: $0.39 loss).
Net debt
As at 31 December 2014, net debt decreased significantly to approximately $12.5m compared with $50.3m at 31 December 2013. Net debt reduced as a result of the Company's IPO in April 2014 and the conversion of the Company's capital notes to shareholders and loans from shareholders into equity.
Cash and cash equivalents
As at 31 December 2014, cash and cash equivalents increased to $11.4m compared with $2.7m at 31 December 2013, as a result of the IPO proceeds.
Outlook
Despite the reduction in sales from the Company's largest customer, the Company expects to continue to grow the revenues from other existing and new customers in the UK and in the US.
Once fully implemented, the recovery plan is expected to reduce the Company's operating costs, improve efficiency and enhance the Company's sales and marketing performance.
In addition, the newly purchased production facility in Ethiopia is expected to give Bagir a strong competitive advantage once the planned upgrades have been implemented.
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
31 December | |||||
2014 | 2013 | ||||
U.S. dollars in thousands | |||||
ASSETS | |||||
CURRENT ASSETS: | |||||
Cash and cash equivalents | 11,420 | 2,670 | |||
Short-term investments | 397 | 600 | |||
Trade receivables | 10,247 | 8,168 | |||
Other receivables | 3,017 | 2,047 | |||
Inventories | 10,379 | 6,620 | |||
35,460 | 20,105 | ||||
NON-CURRENT ASSETS: | |||||
Investment in a joint venture | 1,765 | - | |||
Bank deposits | - | 290 | |||
Property, plant and equipment | 1,308 | 1,595 | |||
Goodwill | 5,689 | 5,689 | |||
Other intangible assets | 4,968 | 7,234 | |||
Deferred taxes | 372 | 486 | |||
14,102 | 15,294 | ||||
49,562 | 35,399 |
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
31 December | |||||
2014 | 2013 | ||||
U.S. dollars in thousands | |||||
LIABILITIES AND EQUITY | |||||
CURRENT LIABILITIES: | |||||
Credit from banks and current maturities of long-term loans | 11,880 | 11,537 | |||
Trade payables | 7,351 | 6,852 | |||
Other payables | 5,597 | 9,773 | |||
24,828 | 28,162 | ||||
NON-CURRENT LIABILITIES: | |||||
Loans from banks | 12,025 | 20,700 | |||
Capital notes to shareholders and loans from shareholders and their related companies | - | 20,748 | |||
Employee benefit liabilities | 456 | 479 | |||
Obligation relating to lease agreement | 155 | 793 | |||
Payable for acquisition of subsidiary | - | 461 | |||
Deferred taxes | 116 | 164 | |||
12,752 | 43,345 | ||||
EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY: | |||||
Share capital | 574 | 30 | |||
Share premium | 78,322 | 27,879 | |||
Capital reserve for share-based payment transactions | 1,444 | 1,411 | |||
Capital reserve for transactions with shareholders | 10,165 | 10,165 | |||
Adjustments arising from translation of foreign operations | (8,895) | (9,111) | |||
Accumulated deficit | (71,574) | (68,428) | |||
10,036 | (38,054) | ||||
Non-controlling interests | 1,946 | 1,946 | |||
Total equity (deficiency) | 11,982 | (36,108) | |||
49,562 | 35,399 |
CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND
OTHER COMPREHENSIVE INCOME
Year ended 31 December | |||||
2014 | 2013 | ||||
U.S. dollars in thousands | |||||
Revenues from sales | 96,982 | 99,490 | |||
Cost of sales | 80,075 | (*80,749 | |||
Gross profit | 16,907 | 18,741 | |||
Selling and marketing expenses | 8,693 | 8,665 | |||
General and administrative expenses | 4,321 | 3,682 | |||
Development costs | 3,198 | (*3,079 | |||
Expenses in connection with IPO | 301 | - | |||
Other income, net | 121 | 289 | |||
Operating income | 515 | 3,604 | |||
Finance income | 6 | 427 | |||
Finance expenses | (3,164) | (3,531) | |||
Finance expenses relating to liabilities to shareholders | (562) | (1,589) | |||
Company's share of losses of a joint venture | (12) | (110) | |||
Other income, net | - | 19 | |||
Loss before taxes on income | (3,217) | (1,180) | |||
Taxes on income (tax benefit) | (39) | 40 | |||
Loss | (3,178) | (1,220) | |||
Other comprehensive income (loss): | |||||
Items to be reclassified or that are reclassified to profit or loss when specific conditions are met: | |||||
Adjustments arising from translation of foreign operations | 216 | (12) | |||
Items not to be reclassified to profit or loss in subsequent periods: | |||||
Remeasurement gain on defined benefit plans | 32 | 6 | |||
Total other comprehensive income (loss) | 248 | (6) | |||
Total comprehensive loss | (2,930) | (1,226) | |||
Loss attributable to equity holders of the Company | (3,178) | (1,220) | |||
Total comprehensive loss attributable to equity holders of the Company | (2,930) | (1,226) |
*) Reclassified.
CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND
OTHER COMPREHENSIVE INCOME
Year ended 31 December | |||||
2014 | 2013 | ||||
U.S. dollars | |||||
Loss per share attributable to equity holders of the Company (in dollars) | |||||
Basic and diluted loss | (0.09) | (0.39) | |||
Weighted average number of Ordinary shares for basic and diluted loss per share *) (in thousands) | 36,486 | 3,125 | |||
*) After share split
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIENCY)
Attributable to equity holders of the Company | ||||||||||||||||||
Share capital | Share premium | Capital reserve for share-based payment transactions | Capital reserve for transactions with shareholders | Adjustments arising from translation of foreign operations | Accumulated deficit | Total | Non-controlling interests | Total equity (deficiency) | ||||||||||
U.S. dollars in thousands | ||||||||||||||||||
Balance at 1 January 2014 | 30 | 27,879 | 1,411 | 10,165 | (9,111) | (68,428) | (38,054) | 1,946 | (36,108) | |||||||||
Loss | - | - | - | - | - | (3,178) | (3,178) | - | (3,178) | |||||||||
Other comprehensive income: | ||||||||||||||||||
Adjustments arising from translation of foreign operations | - | - | - | - | 216 | - | 216 | - | 216 | |||||||||
Remeasurement gain on defined benefit plans | - | - | - | - | - | 32 | 32 | - | 32 | |||||||||
Total other comprehensive income | - | - | - | - | 216 | 32 | 248 | - | 248 | |||||||||
Total comprehensive income (loss) | - | - | - | - | 216 | (3,146) | (2,930) | - | (2,930) | |||||||||
Issue of share capital (net of issue expenses of $ 3.8 million) | 412 | 29,265 | - | - | - | - | 29,677 | - | 29,677 | |||||||||
Conversion of capital notes to shareholders and loans from shareholders into shares | 132 | 21,178 | - | - | - | - | 21,310 | - | 21,310 | |||||||||
Cost of share-based payment | - | - | 33 | - | - | - | 33 | - | 33 | |||||||||
Balance at 31 December 2014 | 574 | 78,322 | 1,444 | 10,165 | (8,895) | (71,574) | 10,036 | 1,946 | 11,982 |
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIENCY)
Attributable to equity holders of the Company | ||||||||||||||||||
Share capital | Share premium | Capital reserve for share-based payment transactions | Capital reserve for transactions with shareholders | Adjustments arising from translation of foreign operations | Accumulated deficit | Total | Non-controlling interests | Total equity (deficiency) | ||||||||||
U.S. dollars in thousands | ||||||||||||||||||
Balance at 1 January 2013 | 30 | 27,879 | 1,367 | 5,623 | (9,099) | (67,214) | (41,414) | 1,946 | (39,468) | |||||||||
Loss | - | - | - | - | - | (1,220) | (1,220) | - | (1,220) | |||||||||
Other comprehensive loss: | ||||||||||||||||||
Adjustments arising from translation of foreign operations | - | - | - | - | (12) | - | (12) | - | (12) | |||||||||
Remeasurement gain on defined benefit plans | - | - | - | - | - | 6 | 6 | - | 6 | |||||||||
Total other comprehensive loss | - | - | - | - | (12) | 6 | (6) | - | (6) | |||||||||
Total comprehensive loss | - | - | - | - | (12) | (1,214) | (1,226) | - | (1,226) | |||||||||
Cost of share-based payment | - | - | 44 | - | - | - | 44 | - | 44 | |||||||||
Capital reserve for capital notes to shareholders and loans from shareholders | - | - | - | 4,542 | - | - | 4,542 | - | 4,542 | |||||||||
Balance at 31 December 2013 | 30 | 27,879 | 1,411 | 10,165 | (9,111) | (68,428) | (38,054) | 1,946 | (36,108) |
CONSOLIDATED STATEMENTS OF CASH FLOWS
Year ended 31 December | ||||
2014 | 2013 | |||
U.S. dollars in thousands | ||||
Cash flows from operating activities: | ||||
Loss | (3,178) | (1,220) | ||
Adjustments to reconcile loss to net cash provided by (used in) operating activities: | ||||
Company's share of losses of a joint venture | 12 | 110 | ||
Depreciation and amortization | 2,829 | 2,487 | ||
Deferred taxes, net | 66 | (48) | ||
Change in employee benefit liabilities | 9 | (97) | ||
Cost of share-based payment | 33 | 44 | ||
Gain from sale of property, plant and equipment | - | (16) | ||
Finance expenses, net | 1,776 | 4,065 | ||
Tax expenses (income), net | (105) | 88 | ||
Other | 476 | 80 | ||
5,096 | 6,713 | |||
Changes in asset and liability items: | ||||
Decrease (increase) in trade receivables | (2,155) | 288 | ||
Decrease (increase) in other receivables | (801) | 1,090 | ||
Decrease (increase) in inventories | (3,827) | 519 | ||
Increase (decrease) in trade payables | 520 | (1,307) | ||
Decrease in other payables | (3,815) | (5,174) | ||
(10,078) | (4,584) | |||
Cash paid (received) during the year for: | ||||
Interest paid | (1,439) | (1,948) | ||
Interest received | 23 | - | ||
Taxes paid | (264) | (2) | ||
(1,680) | (1,950) | |||
Net cash used in operating activities | (9,840) | (1,041) |
CONSOLIDATED STATEMENTS OF CASH FLOWS
Year ended 31 December | ||||
2014 | 2013 | |||
U.S. dollars in thousands | ||||
Cash flows from investing activities: | ||||
Investment in joint venture | (1,657) | - | ||
Purchase of property, plant and equipment | (148) | (258) | ||
Proceeds from sale of property, plant and equipment | - | 16 | ||
Capitalisation of development costs | (150) | - | ||
Realisation of short-term investments, net | 203 | 11 | ||
Bank deposits, net | 290 | - | ||
Proceeds from sale of assets held for sale | - | 607 | ||
Proceeds from sale of investment in a joint venture | - | 2,707 | ||
Dividend from a joint venture | - | 442 | ||
Net cash provided by (used in) investing activities | (1,462) | 3,525 | ||
Cash flows from financing activities: | ||||
Issue of shares, net of expenses | 29,677 | - | ||
Receipt of loans from banks | 3,000 | 23,000 | ||
Payment of loans from banks | (10,797) | (12,891) | ||
Decrease in short-term credit, net | (530) | (12,244) | ||
Repayment of liability for acquisition of subsidiary | (1,250) | (939) | ||
Net cash provided by (used in) financing activities | 20,100 | (3,074) | ||
Translation differences on balances of cash and cash equivalents of foreign operations | (48) | (15) | ||
Increase (decrease) in cash and cash equivalents | 8,750 | (605) | ||
Cash and cash equivalents at the beginning of the year | 2,670 | 3,275 | ||
Balance of cash and cash equivalents at the end of the year | 11,420 | 2,670 |
Non-cash transactions: | ||||
Conversion of capital notes to shareholders and loans from shareholders into shares | 21,310 | - | ||
Payables for investment in joint venture | 120 | - | ||
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1:- GENERAL
a. Company description:
Bagir Group Ltd. ("the Company") is registered in Israel. The Company and its subsidiaries ("the Group") specialise in the manufacturing and marketing of men's and women's tailored fashion. The Company's Headquarters are located in Kiryat Gat, Israel. The Group's products are manufactured by a subsidiary and subcontractors. The Group's products are marketed in Europe (mainly in the U.K.), the U.S. and in other countries.
b. In April 2014 the Company completed an initial public offering ("IPO") and its shares were admitted to trading on the London Stock Exchange's Alternative Investment Market (AIM). In the IPO, the Company issued 35,714,285 Ordinary shares at a price of 56 pence per Ordinary share. The total gross funds raised in the IPO were GBP 20 million ($33.5 million) and IPO related costs amounted to approximately $3.8 million.
Concurrent with the IPO, the Company issued 11,383,925 Ordinary shares to certain shareholders in consideration for the extinguishment of all capital notes and loans due to these shareholders with a carrying amount of approximately $21,310 thousand (par value of approximately $25,989 thousand).
NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES
Assessment of going concern:
The Board has adopted the going concern basis of accounting in preparing the financial statements. In assessing the appropriateness of doing so the Board has considered the principal risks and uncertainties of the business, the trading forecasts covering a twelve months period following the approval of the financial statements (including downside sensitivities) and the debt facilities provided by the Company's banks and the covenants relating to those facilities.
NOTE 3:- NET EARNINGS (LOSS) PER SHARE
Details of the number of shares and loss used in the computation of basic and diluted loss per share:
Year ended 31 December | ||||||
2014 | 2013 | |||||
Weighted number of shares (1) | Loss from operations | Weighted number of shares (1) | Loss from operations | |||
In thousands | U.S. dollars in thousands | In thousands | U.S. dollars in thousands | |||
(2) 36,486 | (3,178) | 3,125 (2) | (1,220) | |||
(1) The data related to the computation of basic and diluted loss per share (options and warrants have not been included as they are antidilutive).
(2) The weighted number or shares are after share split.
Related Shares:
BAGR.L